spacer
spacer

PDBsum entry 1dtt

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/transferase PDB id
1dtt

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
541 a.a. *
412 a.a. *
Ligands
FTC
* Residue conservation analysis
PDB id:
1dtt
Name: Hydrolase/transferase
Title: Crystal structure of HIV-1 reverse transcriptase in complex with pett- 2 (pett130a94)
Structure: HIV-1 rt a-chain. Chain: a. Fragment: p66. Engineered: yes. HIV-1 rt b-chain. Chain: b. Fragment: p51. Engineered: yes
Source: Human immunodeficiency virus 1. Organism_taxid: 11676. Expressed in: bacteria. Expression_system_taxid: 2. Expression_system_taxid: 2
Biol. unit: Dimer (from PQS)
Resolution:
3.00Å     R-factor:   0.199     R-free:   0.276
Authors: J.Ren,J.Diprose,J.Warren,R.M.Esnouf,L.E.Bird,S.Ikemizu,M.Slater, J.Milton,J.Balzarini,D.I.Stuart,D.K.Stammers
Key ref:
J.Ren et al. (2000). Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses. J Biol Chem, 275, 5633-5639. PubMed id: 10681546 DOI: 10.1074/jbc.275.8.5633
Date:
13-Jan-00     Release date:   02-Apr-00    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P04585  (POL_HV1H2) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1435 a.a.
541 a.a.*
Protein chain
Pfam   ArchSchema ?
P04585  (POL_HV1H2) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1435 a.a.
412 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class 1: Chains A, B: E.C.2.7.7.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 2: Chains A, B: E.C.2.7.7.49  - RNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 3: Chains A, B: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 4: Chains A, B: E.C.3.1.-.-
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 5: Chains A, B: E.C.3.1.13.2  - exoribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
   Enzyme class 6: Chains A, B: E.C.3.1.26.13  - retroviral ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 7: Chains A, B: E.C.3.4.23.16  - HIV-1 retropepsin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1074/jbc.275.8.5633 J Biol Chem 275:5633-5639 (2000)
PubMed id: 10681546  
 
 
Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses.
J.Ren, J.Diprose, J.Warren, R.M.Esnouf, L.E.Bird, S.Ikemizu, M.Slater, J.Milton, J.Balzarini, D.I.Stuart, D.K.Stammers.
 
  ABSTRACT  
 
Most non-nucleoside reverse transcriptase (RT) inhibitors are specific for HIV-1 RT and demonstrate minimal inhibition of HIV-2 RT. However, we report that members of the phenylethylthiazolylthiourea (PETT) series of non-nucleoside reverse transcriptase inhibitors showing high potency against HIV-1 RT have varying abilities to inhibit HIV-2 RT. Thus, PETT-1 inhibits HIV-1 RT with an IC(50) of 6 nM but shows only weak inhibition of HIV-2 RT, whereas PETT-2 retains similar potency against HIV-1 RT (IC(50) of 5 nM) and also inhibits HIV-2 RT (IC(50) of 2.2 microM). X-ray crystallographic structure determinations of PETT-1 and PETT-2 in complexes with HIV-1 RT reveal the compounds bind in an overall similar conformation albeit with some differences in their interactions with the protein. To investigate whether PETT-2 could be acting at a different site on HIV-2 RT (e.g. the dNTP or template primer binding site), we compared modes of inhibition for PETT-2 against HIV-1 and HIV-2 RT. PETT-2 was a noncompetitive inhibitor with respect to the dGTP substrate for both HIV-1 and HIV-2 RTs. PETT-2 was also a noncompetitive inhibitor with respect to a poly(rC).(dG) template primer for HIV-2 RT. These results are consistent with PETT-2 binding in corresponding pockets in both HIV-1 and HIV-2 RT with amino acid sequence differences in HIV-2 RT affecting the binding of PETT-2 compared with PETT-1.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Simulated annealing omit electron density maps showing the bound inhibitors at the NNRTI pocket of HIV-1 RT. a, PETT-1; b, PETT-2. The maps are contoured at 4 .
Figure 4.
Fig. 4. . Schematic diagrams showing the intermolecular interactions between PETT inhibitors (in red) and the surrounding residues of HIV-1 RT for (a) PETT-1 and (b) PETT-2. Residues that contact the NNRTI with a minimum inter-atomic distance of 3.6 Å are shown in green, whereas other residues lining the binding pocket are shown in blue. The individual distances between the NNRTI and the protein atoms are shown as dashed lines (distances 3.3 Å in pink, 3.3 Å < distances 3.6 Å in light blue). Hydrogen bonds together with their distances are shown in black.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2000, 275, 5633-5639) copyright 2000.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20358252 A.Herschhorn, and A.Hizi (2010).
Retroviral reverse transcriptases.
  Cell Mol Life Sci, 67, 2717-2747.  
20731670 Z.Xiaohe, Q.Yu, Y.Hong, S.Xiuqing, and Z.Rugang (2010).
Synthesis, biological evaluation and molecular modeling studies of N-aryl-2-arylthioacetamides as non-nucleoside HIV-1 reverse transcriptase inhibitors.
  Chem Biol Drug Des, 76, 330-339.  
18372072 N.Sluis-Cremer, and G.Tachedjian (2008).
Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors.
  Virus Res, 134, 147-156.  
18996020 R.Hunter, Y.Younis, C.I.Muhanji, T.L.Curtin, K.J.Naidoo, M.Petersen, C.M.Bailey, A.Basavapathruni, and K.S.Anderson (2008).
C-2-aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors.
  Bioorg Med Chem, 16, 10270-10280.  
17949071 G.Barreiro, C.R.Guimarães, I.Tubert-Brohman, T.M.Lyons, J.Tirado-Rives, and W.L.Jorgensen (2007).
Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring.
  J Chem Inf Model, 47, 2416-2428.  
16911530 J.Ren, C.E.Nichols, A.Stamp, P.P.Chamberlain, R.Ferris, K.L.Weaver, S.A.Short, and D.K.Stammers (2006).
Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
  FEBS J, 273, 3850-3860.
PDB codes: 2hnd 2hny 2hnz
16163450 J.L.Medina-Franco, A.Golbraikh, S.Oloff, R.Castillo, and A.Tropsha (2005).
Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining.
  J Comput Aided Mol Des, 19, 229-242.  
14748000 F.Daeyaert, M.de Jonge, J.Heeres, L.Koymans, P.Lewi, M.H.Vinkers, and P.A.Janssen (2004).
A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets.
  Proteins, 54, 526-533.  
15220416 J.Auwerx, M.Stevens, A.R.Van Rompay, L.E.Bird, J.Ren, E.De Clercq, B.Oberg, D.K.Stammers, A.Karlsson, and J.Balzarini (2004).
The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
  J Virol, 78, 7427-7437.  
15249669 J.D.Pata, W.G.Stirtan, S.W.Goldstein, and T.A.Steitz (2004).
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.
  Proc Natl Acad Sci U S A, 101, 10548-10553.
PDB code: 1tv6
15229890 M.Barbany, H.Gutiérrez-de-Terán, F.Sanz, and J.Villà-Freixa (2004).
Towards a MIP-based alignment and docking in computer-aided drug design.
  Proteins, 56, 585-594.  
15544453 N.Sluis-Cremer, N.A.Temiz, and I.Bahar (2004).
Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.
  Curr HIV Res, 2, 323-332.  
15306558 O.J.D'Cruz, P.Samuel, and F.M.Uckun (2004).
PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide.
  Biol Reprod, 71, 2037-2047.  
12805462 K.Post, J.Guo, K.J.Howard, M.D.Powell, J.T.Miller, A.Hizi, S.F.Le Grice, and J.G.Levin (2003).
Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription.
  J Virol, 77, 7623-7634.  
12386343 J.Ren, L.E.Bird, P.P.Chamberlain, G.B.Stewart-Jones, D.I.Stuart, and D.K.Stammers (2002).
Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.
  Proc Natl Acad Sci U S A, 99, 14410-14415.
PDB code: 1mu2
12004281 S.C.Houston, L.J.Miedzinski, and L.D.Mashinter (2002).
Rapid progression of CD4 cell decline and subsequent response to salvage therapy in HIV-2 infection.
  AIDS, 16, 1189-1191.  
11080630 J.Ren, J.Milton, K.L.Weaver, S.A.Short, D.I.Stuart, and D.K.Stammers (2000).
Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase.
  Structure, 8, 1089-1094.
PDB codes: 1fk9 1fko 1fkp
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer